Journal of Personalized Medicine,
Journal Year:
2023,
Volume and Issue:
13(9), P. 1302 - 1302
Published: Aug. 25, 2023
(1)
Background:
To
examine
miR-429-meditated
DEAD
(Asp-Glu-Ala-Asp)
box
polypeptide
53
(DDX53)
function
in
endometrial
cancer
(EC).
(2)
Methods:
DDX53
and
miR-429
levels
were
measured
using
quantitative
real-time
polymerase
chain
reaction
western
blotting
assays,
cell
invasion
migration
Transwell
wound
healing
proliferation
colony-forming/proliferation
assays.
A
murine
xenograft
model
was
also
generated
to
functions
vivo.
(3)
Results:
overexpression
(OE)
promoted
key
phenotypes
(proliferation,
migration,
invasion)
EC,
while
vivo,
OE
hindered
tumor
growth
the
model.
Moreover,
identified
as
a
novel
miRNA-targeting
DDX53,
which
suppressed
EC
invasion.
(4)
Conclusions:
regulatory
mechanisms
could
provide
molecular
therapies
for
EC.
Mutations
in
the
RNA
helicase,
DDX3X
,
are
a
leading
cause
of
Intellectual
Disability
and
present
as
syndrome,
neurodevelopmental
disorder
associated
with
cortical
malformations
autism.
Yet,
cellular
molecular
mechanisms
by
which
controls
development
largely
unknown.
Here,
using
mouse
model
Ddx3x
loss-of-function
we
demonstrate
that
directs
translational
cell
cycle
control
neural
progenitors,
underlies
precise
corticogenesis.
First,
show
brain
is
sensitive
to
dosage;
complete
loss
from
progenitors
causes
microcephaly
females,
whereas
hemizygous
males
heterozygous
females
reduced
neurogenesis
without
marked
microcephaly.
In
addition,
sexually
dimorphic,
its
paralog,
Ddx3y
compensates
for
developing
male
neocortex.
Using
live
imaging
promotes
neuronal
generation
regulating
both
duration
neurogenic
divisions.
Finally,
use
ribosome
profiling
vivo
discover
repertoire
translated
transcripts
including
those
DDX3X-dependent
essential
neurogenesis.
Our
study
reveals
invaluable
new
insights
into
etiology
implicating
dysregulated
progenitor
dynamics
translation
pathogenic
mechanisms.
Journal of Medicinal Chemistry,
Journal Year:
2022,
Volume and Issue:
65(9), P. 6390 - 6418
Published: April 29, 2022
Herein,
we
discuss
more
than
50
cyclin-dependent
kinase
(CDK)
inhibitors
that
have
been
approved
or
undergone
clinical
trials
and
their
therapeutic
application
in
multiple
cancers.
This
review
discusses
the
design
strategies,
structure–activity
relationships,
efficacy
performances
of
these
selective
nonselective
CDK
inhibitors.
The
theoretical
basis
early
broad-spectrum
is
similar
to
scope
chemotherapy,
but
because
toxicity
greater
benefit,
there
no
window.
notion
a
safer
potential
pan-CDK
has
widely
recognized
during
research
process.
Four
CDK4/6
for
treatment
breast
cancer
prophylactic
administration
chemotherapy
protect
bone
marrow
immune
system
function.
Furthermore,
emerging
strategies
field
are
summarized
briefly,
CDKs
continue
be
pursued
as
anticancer
drug
targets
discovery.
Journal of Biological Chemistry,
Journal Year:
2024,
Volume and Issue:
300(7), P. 107413 - 107413
Published: May 27, 2024
Ataxin-2
(Atx2)
is
a
polyglutamine
(polyQ)
tract-containing
RNA-binding
protein,
while
its
polyQ
expansion
may
cause
protein
aggregation
that
implicated
in
the
pathogenesis
of
neurodegenerative
diseases
such
as
spinocerebellar
ataxia
type
2
(SCA2).
However,
molecular
mechanism
underlying
how
Atx2
contributes
to
proteinopathies
remains
elusive.
Here,
we
investigated
influence
on
assembly
and
functionality
cellular
processing
bodies
(P-bodies)
by
using
biochemical
fluorescence
imaging
approaches.
We
have
revealed
polyQ-expanded
(PQE)
sequesters
DEAD-box
RNA
helicase
(DDX6),
an
essential
component
P-bodies,
into
aggregates
or
puncta
via
some
sequences.
The
N-terminal
like-Sm
(LSm)
domain
(residues
82-184)
C-terminal
DDX6
are
responsible
for
interaction
specific
sequestration.
Moreover,
sequestration
aggravate
pre-mRNA
mis-splicing,
interfere
with
releasing
endoribonuclease
MARF1
promotes
mRNA
decay
translational
repression.
Rescuing
level
can
recover
P-bodies
preventing
targeted
from
degradation.
This
study
provides
line
evidence
P-body
components
impairment
homeostasis
dysregulating
metabolism,
which
disease
pathologies
potential
therapeutic
target.
Journal of Experimental & Clinical Cancer Research,
Journal Year:
2023,
Volume and Issue:
42(1)
Published: Aug. 19, 2023
Abstract
There
is
increasing
evidence
indicating
the
significant
role
of
DDX5
(also
called
p68),
acting
as
a
master
regulator
and
potential
biomarker
target,
in
tumorigenesis,
proliferation,
metastasis
treatment
resistance
for
cancer
therapy.
However,
has
also
been
reported
to
act
an
oncosuppressor.
These
seemingly
contradictory
observations
can
be
reconciled
by
DDX5’s
DNA
repair.
This
because
cell
apoptosis
malignant
transformation
represent
two
possible
outcomes
single
process
regulated
DDX5,
reflecting
different
intensity
damage.
Thus,
targeting
could
potentially
shift
cells
from
growth-arrested
state
(necessary
repair)
killing.
In
addition
increasingly
recognized
global
genome
stability
surveillance
damage
repair,
implicated
multiple
oncogenic
signaling
pathways.
appears
utilize
distinct
cascades
via
interactions
with
unique
proteins
types
tissues/cells
elicit
opposing
roles
(e.g.,
smooth
muscle
versus
cells).
Such
features
make
intriguing
therapeutic
target
human
cancers,
limited
low
toxicity
normal
tissues.
this
review,
we
discuss
multifaceted
functions
repair
cancer,
immune
suppression,
metabolic
rewiring,
virus
infection
promotion,
negative
impact
on
microbiome
(microbiota).
We
provide
new
data
showing
that
FL118,
molecular
glue
degrader,
selectively
works
against
current
treatment-resistant
prostate
organoids/cells.
Altogether,
studies
demonstrate
may
oncotarget
effectively
conquering
minimal
Advanced Science,
Journal Year:
2022,
Volume and Issue:
9(31)
Published: Sept. 18, 2022
Abstract
In
eukaryotic
cells,
biological
activities
are
executed
in
distinct
cellular
compartments
or
organelles.
Canonical
organelles
with
membrane‐bound
structures
well
understood.
Cells
also
inherently
contain
versatile
membrane‐less
(MLOs)
that
feature
liquid
gel‐like
bodies.
A
biophysical
process
termed
liquid–liquid
phase
separation
(LLPS)
elucidates
how
MLOs
form
through
dynamic
biomolecule
assembly.
LLPS‐related
molecules
often
have
multivalency,
which
is
essential
for
low‐affinity
inter‐
intra‐molecule
interactions
to
trigger
separation.
Accumulating
evidence
shows
LLPS
concentrates
and
organizes
desired
segregates
unneeded
cells.
Thus,
tunable
functional
specificity
response
environmental
stimuli
metabolic
processes.
Aberrant
widely
associated
several
hallmarks
of
cancer,
including
sustained
proliferative
signaling,
growth
suppressor
evasion,
cell
death
resistance,
telomere
maintenance,
DNA
damage
repair,
etc.
Insights
into
the
molecular
mechanisms
provide
new
insights
cancer
therapeutics.
Here,
current
understanding
emerging
concepts
its
involvement
comprehensively
reviewed.
Cells,
Journal Year:
2022,
Volume and Issue:
11(10), P. 1608 - 1608
Published: May 11, 2022
DEAD/H-box
proteins
are
the
largest
family
of
RNA
helicases
in
mammalian
genomes,
and
they
present
all
kingdoms
life.
Since
their
discovery
late
1980s,
have
been
a
major
focus
study.
They
found
to
play
central
roles
metabolism,
gene
expression,
signal
transduction,
programmed
cell
death,
immune
response
bacterial
viral
infections.
Aberrant
functions
implicated
wide
range
human
diseases
that
include
cancer,
neurodegeneration,
inherited
genetic
disorders.
In
this
review,
we
provide
historical
context
discuss
molecular
proteins,
highlighting
recent
discoveries
linking
dysregulation
diseases.
We
will
also
state
knowledge
regarding
two
specific
critical
responses
DDX3X
DDX58,
known
as
RIG-I.
Given
importance
homeostasis
disease,
an
improved
understanding
protein
biology
protein–protein
interactions
be
for
informing
strategies
counteract
pathogenesis
associated
with
several
Molecules,
Journal Year:
2023,
Volume and Issue:
28(24), P. 8060 - 8060
Published: Dec. 13, 2023
Cell
division
in
eukaryotes
is
a
highly
regulated
process
that
critical
to
the
life
of
cell.
Dysregulated
cell
proliferation,
often
driven
by
anomalies
Cyclin-dependent
kinase
(CDK)
activation,
key
pathological
mechanism
cancer.
Recently,
selective
CDK4/6
inhibitors
have
shown
clinical
success,
particularly
treating
advanced-stage
estrogen
receptor
(ER)-positive
and
human
epidermal
growth
factor
2
(HER2)-negative
breast
This
review
provides
an
in-depth
analysis
action
recent
advancements
inhibitors,
categorizing
them
based
on
their
structural
characteristics
origins.
Furthermore,
it
explores
proteolysis
targeting
chimers
(PROTACs)
CDK4/6.
We
hope
this
could
be
benefit
for
further
research
PROTACs.
BioEssays,
Journal Year:
2022,
Volume and Issue:
44(11)
Published: Oct. 12, 2022
Abstract
Before
a
cell
divides
into
two
daughter
cells,
it
typically
doubles
not
only
its
DNA,
but
also
mass.
Numerous
studies
in
cells
ranging
from
yeast
to
mammals
have
shown
that
cellular
growth,
stimulated
by
nutrients
and/or
growth
factor
signaling,
is
prerequisite
for
cycle
progression
most
types
of
cells.
The
textbook
view
growth‐regulated
cycles
signaling
activates
the
transcription
G1
Cyclin
genes
induce
proliferation,
and
stimulates
anabolic
metabolism
parallel.
However,
genetic
knockout
tests
model
organisms
indicate
this
whole
story,
new
show
additional,
“smarter”
mechanisms
help
coordinate
with
itself.
Here
we
summarize
recent
advances
field,
discuss
current
models
which
regulates
proliferation
targeting
core
regulators
via
non‐transcriptional
mechanisms.
Cancers,
Journal Year:
2025,
Volume and Issue:
17(4), P. 570 - 570
Published: Feb. 7, 2025
Background:
Pancreatic
ductal
adenocarcinoma
(PDAC)
is
a
highly
lethal
cancer.
Late
diagnosis
and
acquisition
of
chemoresistance
contribute
to
its
dismal
prognosis.
While
surgical
resection
improved
the
clinical
outcome
patients,
only
~20%
them
are
eligible
due
advanced
disease
at
diagnosis.
Thus,
development
new
therapeutic
approaches
master
priority
for
an
management
this
The
helicase
DDX21
was
proposed
as
prognostic
marker
in
several
tumors,
including
PDAC.
Methods:DDX21
expression
evaluated
PDAC
samples
cell
lines;
RNA
sequencing
bioinformatics
analyses
DDX21-depleted
PANC-1
silenced
cells;
functional
autophagy,
cycle
proliferation.
Results:
expressed
higher
levels
liver
metastasis
patients.
Transcriptomics
cells
revealed
enrichment
genes
involved
autophagy
progression.
inactivation
by
interference
enhanced
basal
autophagic
flux
altered
reducing
rate
G1-S
transition.
Coherently,
proliferation
clonogenic
activity
significantly
reduced.
Conclusions:
Our
results
support
oncogenic
role
uncover
regulation
autophagy.